返回成功案例
消费与零售 | 医疗健康

APT Pharma Limited has acquired Universal Pharmaceutical Labs

APT Pharma Limited, a subsidiary of Jacobson Pharma Group, has acquired the entire shareholding in Universal Pharmaceutical Laboratories Ltd, a subsidiary of Li & Fung Group, for US$10.8 million.

APT Pharma Limited is a leading pharmaceutical manufacturer in Hong Kong, with manufacturing plants in both Hong Kong and Zhongshan.

Universal Pharmaceutical Laboratories Ltd manufactures and distributes private labeled pharmaceuticals, imported pharmaceuticals, health food and nutritional supplements, and various health and beauty care products in Hong Kong.

Li & Fung Group operates three core businesses: it designs, develops and sources consumer products for retailers worldwide; the group operates extensive logistics and distribution networks serving major brands globally. Another core business is retailing, where the company offers convenience stores and bakeries through Convenience Retail Asia Limited, luxury menswear through Trinity Limited, and toys and children's products through Toys (Labuan) Holding Limited.

Oaklins' team in Hong Kong advised the shareholders of APT Pharma Limited in this transaction.

我们的服务
交易方

联系交易团队

 Richard  Winter

Richard Winter

资深顾问
香港, 中国
Quam Capital

相关交易

CARSO Group has acquired a majority stake in AQCF Group
私募基金 | 商业与营运支持服务 | 医疗健康

CARSO Group has acquired a majority stake in AQCF Group

CARSO Group, a leading provider of testing services, has acquired a majority stake in AQCF Group, a key player in the field of food safety.

更多信息
Prestige Inhome Care has found a long-term strategic partner
医疗健康

Prestige Inhome Care has found a long-term strategic partner

Prestige Inhome Care has received a growth capital investment from Yorkway Private. The newly formed partnership will provide growth capital for geographic expansion, increasing Prestige’s range of services and potential future acquisitions. The investment in Prestige is in line with Yorkway’s mandate to invest in leading Australian mid-market companies with strong management teams, backed by significant growth tail winds, as is the case in the aged care industry.

更多信息
Cara Care has been acquired by Mahana Therapeutics
私募基金 | 医疗健康 | 科技、媒体及通讯

Cara Care has been acquired by Mahana Therapeutics

Mahana Therapeutics Inc., renowned for its pioneering digital treatments targeting chronic health issues, has recently finalized the acquisition of Cara Care (HiDoc Technologies GmbH). Cara Care stands out as a premier digital health platform and an official digital health application (DiGA) dedicated to enhancing gut health. This acquisition, supported by key investors Lux Capital and Jazz Ventures Partners, perfectly aligns with Mahana’s expansion strategy.

更多信息